Investment analysts at StockNews.com initiated coverage on shares of Horizon Therapeutics Public (NASDAQ:HZNP – Get Free Report) in a note issued to investors on Monday. The firm set a “buy” rating on the biopharmaceutical company’s stock. Separately, TheStreet cut Horizon Therapeutics Public from a “b-” rating to a “c+” rating in a research report on […]
First National Bank of Omaha trimmed its holdings in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP – Free Report) by 54.2% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 46,651 shares of the biopharmaceutical company’s stock after selling 55,282 […]
Desjardins Global Asset Management Inc. decreased its holdings in Horizon Therapeutics Public Limited (NASDAQ:HZNP – Free Report) by 18.7% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,124 shares of the biopharmaceutical company’s stock after selling 489 shares during the period. Desjardins Global […]
Eversept Partners LP lowered its position in Horizon Therapeutics Public Limited (NASDAQ:HZNP – Get Rating) by 16.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,064,446 shares of the biopharmaceutical company’s stock after selling 205,145 shares during […]
StockNews.com assumed coverage on shares of Horizon Therapeutics Public (NASDAQ:HZNP – Get Rating) in a report published on Sunday. The firm issued a buy rating on the biopharmaceutical company’s stock. Separately, TheStreet downgraded Horizon Therapeutics Public from a b- rating to a c+ rating in a research note on Monday, May 8th. Eight research analysts […]